Loading...

MERCK Kommanditgesellschaft auf Aktien

MKGAFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$134.53
$4.33(3.33%)

MERCK Kommanditgesellschaft auf Aktien (MKGAF) Stock Overview

Explore MERCK Kommanditgesellschaft auf Aktien’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap55.4B
P/E Ratio17.55
EPS (TTM)$7.61
ROE0.10%
Fundamental Analysis

AI Price Forecasts

1 Week$136.67
1 Month$109.51
3 Months$142.22
1 Year Target$157.51

MKGAF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of MERCK Kommanditgesellschaft auf Aktien (MKGAF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.91, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $157.51.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 17.55 and a market capitalization of 55.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;